View All Information for Patients & Visitors »

New to MyHealth?

Manage Your Care From Anywhere.

Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.

Activate Your Account with an access code or Create a New Account

MyHealth for Mobile

The MyHealth mobile app puts all your health information at your fingertips and makes managing your health care simple and quick. Available for iPhone and Android.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Hepatologist, Transplant hepatologist

Associate Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center

Bio: Dr. Nguyen is a clinician investigator. She is currently Associate Professor of Medicine and Director for the Hepatology Fellowship in the Division of Gastroenterology and Hepatology and Liver Transplant Program at Stanford University Medical Center and Director for the Hepatology Clerkship for Stanford University School of Medicine. She is also a member of the Stanford Cancer Institute and Bio-X and a Fellow of the American Association for the Study of Liver Diseases.

She has a large and comprehensive practice of general liver as well as liver transplant patients at Stanford University Medical Center and weekly outreach clinics in the San Jose and monthly clinics in San Francisco area. Her research areas include epidemiology, clinical outcomes, translational studies, and therapeutic clinical trials for chronic hepatitis B, chronic hepatitis C, liver cancer/tumors, other chronic liver diseases as cause of liver cancer such as nonalcoholic fatty liver disease and liver transplant-related issues. She has mentored over 120 trainees of diverse backgrounds and levels of training. Her research lab includes trainees who are high school students, undergraduate students, medical students, graduate students in the Masters' in Epidemiology Program or Public Health, interns/residents, gastroenterology/hepatology fellows, junior faculty, and international visiting scholars. She also serves as Pre-Major Academic Advisor for the undergraduate school.

Her research base includes single-center Stanford-based cohorts, multi-center Bay Area consortium, multi-center US consortia as well as collaborative international cohorts.

She is active in community outreach efforts locally and nationally including service as executive board of director for nonprofit organizations. She serves in the Education and Hepatology Associate Committees for the American Association for the Study of Liver Diseases (AASLD), as member of the Steering Committee for the Hepatobiliary Neoplasia Special Interest Group at AASLD, and has served as member of the Editorial Board for various journals including Gastroenterology and Hepatology.

As Faculty Fellow at the Center for Innovation in Global Health at Stanford University, Dr. Nguyen is active in Global Health with research collaboration and medical education program and exchanges, with ongoing work in and with several countries in the Asia Pacific region.

She is a Fellow of the American Association for the Study of Liver Diseases and American Gastroenterological Association Fellow, She is also a member of the European Association for the Study of Liver Diseases, the Asia Pacific Association for the Study of Liver Diseases, and the International Liver Cancer Association.

Read Full Bio

Summary
Clinical Trials
Reviews

4.7 out of 5

228 Patient Ratings
42 Patient Comments

Liver Transplant Program

300 Pasteur Drive
Stanford , CA 94305
Phone: 650-498-7878

More Clinic Information »

Liver Clinic (Hepatology)

900 Blake Wilbur Drive
Palo Alto , CA 94304
Phone: 650-498-7999

More Clinic Information »

Digestive Health Center

900 Blake Wilbur Drive
Palo Alto , CA 94304
Phone: 650-736-5555

More Clinic Information »

Liver Transplant Program in San Jose, O'Connor Drive

231 O'Connor Drive
San Jose , CA 95128
Phone: 650-725-1988

More Clinic Information »

Liver Transplant Program in San Jose, Jose Figueres Avenue

200 Jose Figueres Avenue
Suite 255
San Jose , CA 95116
Phone: 650-725-1988

More Clinic Information »

Summary
Clinical Trials
Reviews

Practice Areas

Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatology (Liver Conditions)
Liver Cancer
Liver Transplant
Polycystic Liver Disease

View All 18 Practice Areas

Professional Education

Fellowship: Stanford University School of Medicine Registrar (2002) CA
Medical Education: University of California San Diego School of Medicine (1992) CA
B.S., University of California, Irvine, Biological Sciences (1988)
M.D., Univ. of California, San Diego, Medicine (1992)
M.A.S., Univ. of Calif., San Francisco, Masters of Advanced Studies in Clinical Research (2004)
Internship: UCSD Medical Center (1995) CA
Residency: UCSD Medical Center (1996) CA
Board Certification: Transplant Hepatology, American Board of Internal Medicine (2010)

View All

Honors & Awards

2015 Divisional Teaching Award, Department of Medicine, Stanford University Medical Center, Palo Alto, CA (2015 Dec)
Advanced Hepatology Research Fellow Award, American Association for the Study of Liver Diseases (2001)
Chief Fellow in Gastroenterology and Hepatology, Stanford University Medical Center (2002)
Chief Resident, University of California, San Diego Medical Center (1996)
Excellence in Teaching Award, University of California, San Diego, School of Medicine (1996)
Magna Cum Laude, University of California, Irvine (1988)
Pacific Free Clinic Physician Service Award, Cardinal Free Clinics, Stanford University School of Medicine (2013 April)
Phi Beta Kappa, University of California, Irvine (1985)
Senior Fellow at the Center for Innovation in Global Health, Center for Innovation in Global Helath, Stanford University, Stanford, CA (2015 Oct)
Stanford Asian American Faculty Awards, The Asian American Activities Center, Stanford University, Stanford, CA (2015 May)
The Franklin Edbaugh Advising Award for Faculty, Stanford University School of Medicine (2013 May)

View All

Administrative Appointments

Abstract review member for the Hepatitis B : Epidemiology/Prevention/Control review group, American Association for the Study of Liver Diseases (AASLD) (2011 - 2016)
CIGH Faculty Fellow, Center for Innovation in Global Health (CIGH), Stanford University (2015 - Present)
Committee Chair, Abstract Review for Chronic Hepatitis B, American Association for the Study of Liver Diseases (AASLD) (2013 - 2013)
Director of Clinical Research, Pacific Health Foundation (2004 - Present)
Director of Continuing Medical Education, Pacific Health Foundation (2005 - 2012)
Director of Hepatology Clerkship, Stanford University School of Medicine (2013 - Present)
Director of Hepatology Fellowship, http://med.stanford.edu/gastrohepfellows/, Stanford University Medical Center (2014 - Present)
Editorial Board, Digestive Diseases and Sciences (2008 - Present)
Editorial Board, Gastroenterology (2011 - Present)
Editorial Board, Hepatology (2017 - 2019)
Education Committee, American Association for the Study of Liver Diseases (AASLD) (2013 - 2016)
Executive Board of Director, Asian Health Foundation (2013 - Present)
Hepatology Associates Committee , MD Liaison, American Association for the Study of Liver Diseases (AASLD) (2013 - 2016)
International Editorial Board, Alimentary Pharmacology and Therapeutics (2018 - 2020)
Liver Section Editor, Journal of Clinical Gastroenterology (2013 - Present)
Medical Advisory Board, American Liver Foundation (2013 - Present)
Steering Committee, HBV Special Interest Group, American Association for the Study of Liver Diseases (AASLD) (2015 - Present)
Steering Committee, Hepatobiliary Neoplasia Special Interest Group, American Association for the Study of Liver Diseases (AASLD) (2014 - 2016)
Training and Workforce Committee, Member, American Association for the Study of Liver Diseases (AASLD) (2002 - 2004)

View All

Publications

Therapeutic advances in the management of hepatitis B and hepatitis C
Nguyen, M. H., & Wright, T. L. (2001). Therapeutic advances in the management of hepatitis B and hepatitis C. CURRENT OPINION IN INFECTIOUS DISEASES, 14(5), 593–601.
Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers?
Nguyen, M. H., & Garcia, G. (2002). Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers? AMERICAN JOURNAL OF GASTROENTEROLOGY, 97(5), 1092–1093.
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis
Nguyen, M. H., Garcia, R. T., Simpson, P. W., Wright, T. L., & Keeffe, E. B. (2002). Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. HEPATOLOGY, 36(2), 410–417.
Screening for hepatocellular carcinoma Nguyen, M. H., & Keeffe, E. B. (2002). Screening for hepatocellular carcinoma. JOURNAL OF CLINICAL GASTROENTEROLOGY, 35(5), S86–S91.
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine Simpson, N. D., Simpson, P. W., Ahmed, A. M., Nguyen, M. H., Garcia, G., Keeffe, E. B., & Ahmed, A. (2003). Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine. JOURNAL OF CLINICAL GASTROENTEROLOGY, 37(1), 68–71.
Chronic hepatitis B and hepatitis C in Asian Americans. Nguyen, M. H., & Keeffe, E. B. (2003). Chronic hepatitis B and hepatitis C in Asian Americans. Reviews in Gastroenterological Disorders, 3(3), 125–134.
Prophylactic clip application Nguyen, M. H., & Soetikno, R. (2003). Prophylactic clip application. GASTROINTESTINAL ENDOSCOPY, 58(6), 941–941.
Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: A multicenter randomized trial Garcia, R. T., Cello, J. P., Nguyen, M. H., Rogers, S. J., Rodas, A., Trinh, H. N., … McQuaid, K. R. (2003). Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: A multicenter randomized trial. GASTROENTEROLOGY, 125(6), 1606–1612.
Use of endoclips in the treatment of massive colonic diverticular bleeding Simpson, P. W., Nguyen, M. H., Lim, J. K., & Soetikno, R. M. (2004). Use of endoclips in the treatment of massive colonic diverticular bleeding. GASTROINTESTINAL ENDOSCOPY, 59(3), 433–437.
Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Nguyen, M. H., & Keeffe, E. B. (2004). Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Reviews in Gastroenterological Disorders, 4, S14–21.
Role of Ethnicity in Risk for Hepatocellular Carcinoma in Patients With Chronic Hepatitis C and Cirrhosis Nguyen, M. H., Whittemore, A. S., Garcia, R. T., Tawfeek, S. A., Ning, J., Lam, S., … Keeffe, E. B. (2004). Role of Ethnicity in Risk for Hepatocellular Carcinoma in Patients With Chronic Hepatitis C and Cirrhosis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2(9), 820–824.
General management Nguyen, M. H., & Keeffe, E. B. (2005). General management. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY, 19(1), 161–174.
The diagnosis and management of benign hepatic tumors Choi, B. Y., & Nguyen, M. H. (2005). The diagnosis and management of benign hepatic tumors. JOURNAL OF CLINICAL GASTROENTEROLOGY, 39(5), 401–412.
Chronic hepatitis C: genotypes 4 to 9. Nguyen, M. H., & Keeffe, E. B. (2005). Chronic hepatitis C: genotypes 4 to 9. Clinics in Liver Disease, 9(3), 411-?
Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Nguyen, M. H., & Keeffe, E. B. (2005). Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clinical Gastroenterology and Hepatology , 3(10), S97–S101.
Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion Ha, B. Y., Ahmed, A., Sze, D. Y., Razavi, M. K., Simpson, N., Keeffe, E. B., & Nguyen, M. H. (2007). Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 26(6), 839–846.
Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels Tsang, P. S. Y., Trinh, H., Garcia, R. T., Phan, J. T., Ha, N. B., Nguyen, H., … Nguyen, M. H. (2008). Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 6(5), 569–574.
Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin Nguyen, M. H., Trinh, H. N., Garcia, R., Nguyen, G., Lam, K. D., & Keeffe, E. B. (2008). Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin. AMERICAN JOURNAL OF GASTROENTEROLOGY, 103(5), 1131–1135.
Low proportion of Barrett's esophagus in Asian Americans Lam, K. D., Phan, J. T., Garcia, R. T., Trinh, H., Nguyen, H., Nguyen, K., … Nguyen, M. H. (2008). Low proportion of Barrett's esophagus in Asian Americans. AMERICAN JOURNAL OF GASTROENTEROLOGY, 103(7), 1625–1630.
Are Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B and HBeAg-Negative Chronic Hepatitis B Distinct Diseases? Nguyen, M. H., & Keeffe, E. B. (2008). Are Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B and HBeAg-Negative Chronic Hepatitis B Distinct Diseases? CLINICAL INFECTIOUS DISEASES, 47(10), 1312–1314.
Prevalence of Colorectal Neoplasms in Asian Americans Lam, K. D., Garcia, R. T., Nguyen, L. H., Trinh, H., Triadafilopoulos, G., Phan, J. T., … Nguyen, M. H. (2009). Prevalence of Colorectal Neoplasms in Asian Americans. DIGESTIVE DISEASES AND SCIENCES, 54(1), 160–167.
Clinical course of hepatitis B virus infection during pregnancy Nguyen, G., Garcia, R. T., Nguyen, N., Trinh, H., Keeffe, E. B., & Nguyen, M. H. (2009). Clinical course of hepatitis B virus infection during pregnancy. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 29(7), 755–764.
Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides Nguyen, M. H., & Keeffe, E. B. (2009). Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides. JOURNAL OF VIRAL HEPATITIS, 16(3), 149–155.
Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation De Luna, W., Sze, D. Y., Ahmed, A., Ha, B. Y., Ayoub, W., Keeffe, E. B., … Nguyen, M. H. (2009). Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 9(5), 1158–1168.
alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., … Schwartz, M. (2009). alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma. GASTROENTEROLOGY, 137(1), 110–118.
Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels Nguyen, M. H., Garcia, R. T., Trinh, H. N., Lam, K. D., Weiss, G., Nguyen, H. A., … Keeffe, E. B. (2009). Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels. AMERICAN JOURNAL OF GASTROENTEROLOGY, 104(9), 2206–2213.
Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil Ha, N. B., Ha, N. B., Garcia, R. T., Trinh, H. N., Vu, A. A., Nguyen, H. A., … Nguyen, M. H. (2009). Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil. HEPATOLOGY, 50(3), 727–734.
Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B Nguyen, L. H., Ha, N. B., Vutien, P., Ha, N. B., Garcia, R. T., Trinh, H. N., … Nguyen, M. H. (2009). Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B. HEPATOLOGY INTERNATIONAL, 3(3), 461–467.
Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B Nguyen, M. H., Garcia, R. T., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., Nguyen, L. H., & Levitt, B. (2009). Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 30(11-12), 1150–1158.
Combination of pharmacologic and endoscopic therapy for the secondary prevention of esophageal variceal bleeding Ayoub, W. S., & Nguyen, M. H. (2009). Combination of pharmacologic and endoscopic therapy for the secondary prevention of esophageal variceal bleeding. GASTROINTESTINAL ENDOSCOPY, 70(4), 665–667.
Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting Wong, C. R., Garcia, R. T., Trinh, H. N., Lam, K. D., Ha, N. B., Nguyen, H. A., … Nguyen, M. H. (2009). Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting. DIGESTIVE DISEASES AND SCIENCES, 54(12), 2712–2721.
Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C Vutien, P., Nguyen, N. H., Trinh, H. N., Li, J., Garcia, R. T., Garcia, G., … Nguyen, M. H. (2010). Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C. AMERICAN JOURNAL OF GASTROENTEROLOGY, 105(5), 1110–15.
Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6 Nguyen, N. H., VuTien, P., Garcia, R. T., Trinh, H., Nguyen, H., Nguyen, K., … Nguyen, M. H. (2010). Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6. JOURNAL OF VIRAL HEPATITIS, 17(10), 691–697.
Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans Nguyen, N. H., Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, L. H., Nguyen, H. A., … Nguyen, M. H. (2010). Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. HEPATOLOGY INTERNATIONAL, 4(2), 523–529.
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery Rhee, S.-Y., Margeridon-Thermet, S., Nguyen, M. H., Liu, T. F., Kagan, R. M., Beggel, B., … Shafer, R. W. (2010). Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery. ANTIVIRAL RESEARCH, 88(3), 269–275.
Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6 Lam, K. D., Trinh, H. N., Do, S. T., Nguyen, T. T., Garcia, R. T., Nguyen, T., … Nguyen, M. H. (2010). Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6. HEPATOLOGY, 52(5), 1573–80.
Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B Ha, N. B., Ha, N. B., Garcia, R. T., Trinh, H. N., Chaung, K. T., Nguyen, H. A., … Nguyen, M. H. (2011). Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B. DIGESTIVE DISEASES AND SCIENCES, 56(8), 2423–2431.
Ethnic Differences in Viral Dominance Patterns in Patients with Hepatitis B Virus and Hepatitis C Virus Dual Infection Nguyen, L. H., Ko, S., Wong, S. S., Tran, P. S., Trinh, H. N., Garcia, R. T., … Nguyen, M. H. (2011). Ethnic Differences in Viral Dominance Patterns in Patients with Hepatitis B Virus and Hepatitis C Virus Dual Infection. HEPATOLOGY, 53(6), 1839–1845.
Systematic review: epidemiology of hepatitis C genotype 6 and its management Chao, D. T., Abe, K., & Nguyen, M. H. (2011). Systematic review: epidemiology of hepatitis C genotype 6 and its management. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 34(3), 286–296.
High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure Wong, C. R., Trinh, H. N., Yip, B., Nguyen, H. A., Garcia, R. T., Ahmed, A., … Nguyen, M. H. (2011). High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure. JOURNAL OF CLINICAL GASTROENTEROLOGY, 45(10), 900–905.
The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir SHEEN, E., Trinh, H. N., Nguyen, T. T., Do, S. T., Tran, P., Nguyen, H. A., … Nguyen, M. H. (2011). The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 34(7), 767–74.
Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients Ho, E. Y., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T., Garcia, G., … Nguyen, M. H. (2012). Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. JOURNAL OF VIRAL HEPATITIS, 19(2), E105–E111.
Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study Ha, N. B., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T. J., Chang, E. T., … Nguyen, M. H. (2012). Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. CANCER CAUSES & CONTROL, 23(3), 455–462.
Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study Zhang, S., Ristau, J. T., Trinh, H. N., Garcia, R. T., Nguyen, H. A., & Nguyen, M. H. (2012). Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study. DIGESTIVE DISEASES AND SCIENCES, 57(5), 1373–1383.
Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies Mair, R. D., Valenzuela, A., Ha, N. B., Ayoub, W. S., Daugherty, T., Lutchman, G. A., … Nguyen, M. H. (2012). Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 10(12), 1412–1417.
High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy Chaung, K. T., Ha, N. B., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Nguyen, K. K., … Nguyen, M. H. (2012). High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy. JOURNAL OF CLINICAL GASTROENTEROLOGY, 46(10), 865–870.
Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders Yip, B., Chaung, K., Wong, C. R., Trinh, H. N., Nguyen, H. A., Ahmed, A., … Nguyen, M. H. (2012). Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders. DIGESTIVE DISEASES AND SCIENCES, 57(11), 3011–3016.
High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver-related Complaints Kin, K. C., Lin, B., Ha, N. B., Chaung, K. T., Trinh, H. N., Garcia, R. T., … Nguyen, M. H. (2013). High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver-related Complaints. JOURNAL OF CLINICAL GASTROENTEROLOGY, 47(4), 367–371.
Response to Higher Dose of Entecavir 1.0 mg Daily in Patients With Partial Response to Entecavir 0.5 mg Daily Ha, N. B., Ha, N. B., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., & Nguyen, M. H. (2013). Response to Higher Dose of Entecavir 1.0 mg Daily in Patients With Partial Response to Entecavir 0.5 mg Daily. JOURNAL OF CLINICAL GASTROENTEROLOGY, 47(5), 461–465.
Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice Liu, A., Ha, N. B., Lin, B., Yip, B., Trinh, H. N., Nguyen, H. A., … Nguyen, M. H. (2013). Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 25(3), 338–343.
Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B VuTien, P., Trinh, H. N., Nguyen, K., Garcia, R. T., Nguyen, H. A., Levitt, B. S., … Nguyen, M. H. (2013). Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 37(4), 464–472.
Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice. Lin, B., Ha, N. B., Liu, A., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., … Nguyen, M. H. (2013). Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice. Journal of Gastroenterology and Hepatology, 28(5), 855–860.
Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy. Nguyen, N. H., Nguyen, V., Trinh, H. N., Lin, B., & Nguyen, M. H. (2013). Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy. Clinical Gastroenterology and Hepatology , 11(5), 565–571.
Systematic review: Asian patients with chronic hepatitis C infection. Nguyen, L. H., & Nguyen, M. H. (2013). Systematic review: Asian patients with chronic hepatitis C infection. Alimentary Pharmacology & Therapeutics, 37(10), 921–936.
Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B Infection in Vietnamese Americans in California Ha, N. B., Trinh, H. N., Nguyen, T. T., Leduc, T.-S., Bui, C., Ha, N. B., … Nguyen, M. H. (2013). Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B Infection in Vietnamese Americans in California. JOURNAL OF CANCER EDUCATION, 28(2), 319–324.
Prevention of mother-to-child transmission of hepatitis B virus: is elective cesarean section in highly viremic mothers an appropriate adjunct to immunoprophylaxis? Nguyen, L. H., & Nguyen, M. H. (2013). Prevention of mother-to-child transmission of hepatitis B virus: is elective cesarean section in highly viremic mothers an appropriate adjunct to immunoprophylaxis? Clinical Gastroenterology and Hepatology , 11(10), 1356–1357.
DIFFERENTIAL MIGRATION OF ASTROCYTES GRAFTED INTO THE DEVELOPING RAT-BRAIN Hatton, J. D., Nguyen, M. H., & U, H. S. (1993). DIFFERENTIAL MIGRATION OF ASTROCYTES GRAFTED INTO THE DEVELOPING RAT-BRAIN. GLIA, 9(2), 113–119.
Treatment of Hepatocellular Carcinoma Treatment of Hepatocellular Carcinoma. (2003). Rustgi AK and Crawford J, Eds. Gastrointestinal Cancer: A Companion to Sleisenger & Fordtran?s GI and Liver Diseases. Philadelphia: WB Saunders, 1st ed.
The role of steatosis in HBV infection The role of steatosis in HBV infection. (2011). Curr Hepat Rep, 10.
Early virologic response in HCV genotype 6 Early virologic response in HCV genotype 6. (2011). Hepatology, 53.
Benign tumors and evaluation of liver masses Benign tumors and evaluation of liver masses. (2005). In: Al Knawy B, Schiffman ML, and Wiesner R, Eds. Hepatology: A Practical Approach, 1st Ed. Amsterdam: Elsevier Science BV.
Chronic HBV infection and normal ALT levels: Underlying histological disease Chronic HBV infection and normal ALT levels: Underlying histological disease. (2007). Curr Hepat Rep, 6.
Hepatitis C virus and cancers: How strong are the relationships? Hepatitis C virus and cancers: How strong are the relationships? (2009). Curr Hepat Rep, 8.
Histologic Disease in Patients with Chronic Hepatitis B, HIgh HBV DNA, and Normal Alanine Aminotransferase Levels Histologic Disease in Patients with Chronic Hepatitis B, HIgh HBV DNA, and Normal Alanine Aminotransferase Levels. (2010). Curr Hepat Rep, 9.
Relationship between HBsAg seroconversion and hepatocellular carcinoma Relationship between HBsAg seroconversion and hepatocellular carcinoma. (2011). J Clin Gastroenterol, 45.
Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection. (2012). Hepatology, 55.
Lead poisoning as an etiology of abdominal pain and intestinal pseudo-obstruction in adults Tran, C. P., Garcia, R. T., Lam, V. T., Trong, T. H., Keeffe, E. B., & Nguyen, M. H. (2004). Lead poisoning as an etiology of abdominal pain and intestinal pseudo-obstruction in adults. AMERICAN JOURNAL OF GASTROENTEROLOGY, 99(10), S105–S105.
Unsedated ultrathin EGD is well accepted by most patients: A randomized trial of unsedated ultrathin EGD (UT-EGD) vs. sedated conventional EGD (C-EGD) Garcia, R. T., Cello, J. P., Rogers, S. J., Rodas, A., Nguyen, M. H., Trinh, H., … McQuaid, K. R. (2002). Unsedated ultrathin EGD is well accepted by most patients: A randomized trial of unsedated ultrathin EGD (UT-EGD) vs. sedated conventional EGD (C-EGD). AMERICAN JOURNAL OF GASTROENTEROLOGY, 97(9), S306–S306.
Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians. Lin, H., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T. J., Lutchman, G. A., … Nguyen, M. H. (2013). Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians. Journal of Immigrant and Minority Health , 15(6), 1023–1029.
Less-established risk factors are common in asian americans with hepatitis C virus: a case-controlled study. Kin, K. C., Lin, B., Chaung, K. T., Ha, N. B., Trinh, H. N., Garcia, R. T., … Nguyen, M. H. (2013). Less-established risk factors are common in asian americans with hepatitis C virus: a case-controlled study. Digestive Diseases and Sciences, 58(11), 3342–3347.
Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma Yip, B., Wantuck, J. M., Kim, L. H., Wong, R. J., Ahmed, A., Garcia, G., & Nguyen, M. H. (2014). Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma. DIGESTIVE DISEASES AND SCIENCES, 59(1), 192–200.
Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6 Wantuck, J. M., Ahmed, A., & Nguyen, M. H. (2014). Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(2), 137–147.
Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies. Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies. (2013). Journal of Clinical Gastroenterology.
Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients. Wong, R. J., Wantuck, J., Valenzuela, A., Ahmed, A., Bonham, C., Gallo, A., … Nguyen, M. H. (2014). Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients. Digestive Diseases and Sciences, 59(1), 183–191.
Mutations in HBV DNA polymerase associated with nucleos(t)ide resistance are rare in treatment-naive patients. Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Levitt, B. S., Nguyen, K., … Nguyen, M. H. (2014). Mutations in HBV DNA polymerase associated with nucleos(t)ide resistance are rare in treatment-naive patients. Clinical Gastroenterology and Hepatology , 12(8), 1363–1370.
Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment-Na < ve Chronic Hepatitis B Patients: A Case-Control Study Ha, N. B., Ha, N. B., Chaung, K. T., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., & Nguyen, M. H. (2014). Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment-Na < ve Chronic Hepatitis B Patients: A Case-Control Study. DIGESTIVE DISEASES AND SCIENCES, 59(1), 168–173.
Chronic Hepatitis B Management Based on Standard Guidelines in Community Primary Care and Specialty Clinics Ku, K. C., Li, J., Ha, N. B., Martin, M., Nguyen, V. G., & Nguyen, M. H. (2013). Chronic Hepatitis B Management Based on Standard Guidelines in Community Primary Care and Specialty Clinics. DIGESTIVE DISEASES AND SCIENCES, 58(12), 3626–3633.
Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. Wong, R. J., Devaki, P., Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. Clinical Gastroenterology and Hepatology , 12(9), 1534–1540 e1.
Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase <= 40 IU/L and significant hepatic fibrosis Chao, D. T., Lim, J. K., Ayoub, W. S., Nguyen, L. H., & Nguyen, M. H. (2014). Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase <= 40 IU/L and significant hepatic fibrosis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(4), 349–358.
Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review Nguyen, L. H., Chao, D., Lim, J. K., Ayoub, W., & Nguyen, M. H. (2014). Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(8), 1262–1266.
Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry Wong, R. J., Devaki, P., Long Nguyen, L., Cheung, R., & Nguyen, M. H. (2014). Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry. LIVER TRANSPLANTATION, 20(5), 528–535.
Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA Gao, L., Trinh, H. N., Li, J., & Nguyen, M. H. (2014). Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(6), 629–637.
Isoniazid hepatotoxicity requiring liver transplantation. Sheen, E., Huang, R. J., Uribe, L. A., & Nguyen, M. H. (2014). Isoniazid hepatotoxicity requiring liver transplantation. Digestive Diseases and Sciences, 59(7), 1370–1374.
Recurrent Hepatocellular Carcinoma and Poorer Overall Survival in Patients Undergoing Left-sided Compared With Right-sided Partial Hepatectomy. Valenzuela, A., Ha, N. B., Gallo, A., Bonham, C., Ahmed, A., Melcher, M., … Nguyen, M. H. (2015). Recurrent Hepatocellular Carcinoma and Poorer Overall Survival in Patients Undergoing Left-sided Compared With Right-sided Partial Hepatectomy. Journal of Clinical Gastroenterology, 49(2), 158–164.
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz, E., Gordon, S. C., Schiff, E., … Kwo, P. (2014). Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. New England Journal of Medicine, 370(16), 1483–1493.
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. Afdhal, N., Zeuzem, S., Kwo, P., Chojkier, M., Gitlin, N., Puoti, M., … Marcellin, P. (2014). Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. The New England Journal of Medicine, 370(20), 1889–98.
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. Kowdley, K. V., Gordon, S. C., Reddy, K. R., Rossaro, L., Bernstein, D. E., Lawitz, E., … Fried, M. W. (2014). Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. The New England Journal of Medicine, 370(20), 1879–88.
Current treatment guidelines for chronic hepatitis B and their applications. Uribe, L. A., O'Brien, C. G., Wong, R. J., Gish, R. R., Tsai, N., & Nguyen, M. H. (2014). Current treatment guidelines for chronic hepatitis B and their applications. Journal of Clinical Gastroenterology, 48(9), 773–783.
Treating hepatitis C in lower-income countries. Jayasekera, C. R., Barry, M., Roberts, L. R., & Nguyen, M. H. (2014). Treating hepatitis C in lower-income countries. New England Journal of Medicine, 370(20), 1869–1871.
Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible--authors' reply. Wantuck, J. M., & Nguyen, M. H. (2014). Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible--authors' reply. Alimentary Pharmacology & Therapeutics, 39(11), 1338-?
Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply. Gao, L., Trinh, H. N., Li, J., & Nguyen, M. H. (2014). Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply. Alimentary Pharmacology & Therapeutics, 39(11), 1339–1340.
Low Treatment Rates in Patients Meeting Guideline Criteria in Diverse Practice Settings Kim, L. H., Nguyen, V. G., Trinh, H. N., Li, J., Zhang, J. Q., & Nguyen, M. H. (2014). Low Treatment Rates in Patients Meeting Guideline Criteria in Diverse Practice Settings. DIGESTIVE DISEASES AND SCIENCES, 59(9), 2091–2099.
Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings Nguyen, V. G., Wan, K., Trinh, H. N., Li, J., Zhang, J. Q., & Nguyen, M. H. (2015). Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings. JOURNAL OF CLINICAL GASTROENTEROLOGY, 49(2), 145–149.
Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies Do, A. L., Wong, C. R., Nguyen, L. H., Nguyen, V. G., Huy Trinh, H., & Nguyen, M. H. (2014). Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies. JOURNAL OF CLINICAL GASTROENTEROLOGY, 48(7), 644–649.
The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. (2014). Virology, 468-470C, 197–206.
Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin. Yee, B. E., Nguyen, N. H., Zhang, B., Vutien, P., Wong, C. R., Lutchman, G. A., & Nguyen, M. H. (2014). Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin. European Journal of Gastroenterology & Hepatology, 26(11), 1189–1201.
Safety and efficacy of entecavir in adefovir-experienced patients Nguyen, N. H., Trinh, H. N., Nguyen, T. T., Do, S. T., Tran, P., Nguyen, H. A., … Nguyen, M. H. (2015). Safety and efficacy of entecavir in adefovir-experienced patients. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30(1), 43–50.
Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score Wong, R. J., Devaki, P., Long Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(9), 1534–U323.
Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1. Kumari, R., & Nguyen, M. H. (2015). Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1. Expert Opinion on Pharmacotherapy, 16(5), 739–748.
Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy. Kim, L. H., Chaung, K. T., Ha, N. B., Kin, K. C., Vu, V. D., Trinh, H. N., … Nguyen, M. H. (2015). Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy. European Journal of Gastroenterology & Hepatology, 27(8), 871–876.
Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy A Matched Case-Cohort Study Ha, N. B., Ku, K., Ha, N. B., Chaung, K. T., Trinh, H. N., & Nguyen, M. H. (2015). Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy A Matched Case-Cohort Study. JOURNAL OF CLINICAL GASTROENTEROLOGY, 49(10), 873–877.
Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir Vo, K. P., Vutien, P., Akiyama, M. J., Vu, V. D., Ha, N. B., Piotrowski, J. I., … Nguyen, M. H. (2015). Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir. DIGESTIVE DISEASES AND SCIENCES, 60(4), 1045–1051.
Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation Ku, W., Wang, U., & Nguyen, M. H. (2015). Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation. EXPERT OPINION ON BIOLOGICAL THERAPY, 15(5), 665–677.
Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin Nguyen, N. H., McCormack, S. A., Vutien, P., Yee, B. E., Devaki, P., Jencks, D., & Nguyen, M. H. (2015). Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin. INTERVIROLOGY, 58(1), 27–34.
Approximately One-Half of Patients With Early-Stage Hepatocellular Carcinoma Meeting Milan Criteria Did Not Receive Local Tumor Destructive or Curative Surgery in the Post-MELD Exception Era Devaki, P., Wong, R. J., Marupakula, V., Nangia, S., Long Nguyen, L., Ditah, I. C., … Nguyen, M. H. (2014). Approximately One-Half of Patients With Early-Stage Hepatocellular Carcinoma Meeting Milan Criteria Did Not Receive Local Tumor Destructive or Curative Surgery in the Post-MELD Exception Era. CANCER, 120(11), 1725–1732.
The genetic diversity and evolutionary history of hepatitis C virus in Vietnam Li, C., Yuan, M., Lu, L., Lu, T., Xia, W., Pham, V. H., … Abe, K. (2014). The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. VIROLOGY, 468, 197–206.
Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients Devaki, P., Jencks, D., Yee, B. E., & Nguyen, M. H. (2015). Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients. HEPATOLOGY INTERNATIONAL, 9(3), 431–437.
Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir. Lu, L., Yip, B., Trinh, H., Pan, C. Q., Han, S. B., Wong, C. C., … Nguyen, M. H. (2015). Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir. Journal of Viral Hepatitis, 22(8), 675–681.
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update Martin, P., Lau, D. T. Y., Nguyen, M. H., Janssen, H. la, Dieterich, D. T., Peters, M. G., & Jacobson, I. M. (2015). A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 13(12), 2071-?
Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks. Nguyen, N. H., McCormack, S. A., Yee, B. E., Devaki, P., Jencks, D., Chao, D. T., & Nguyen, M. H. (2014). Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks. Hepatology International, 8(4), 540–549.
Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. Vu, V. D., Do, A., Nguyen, N. H., Kim, L. H., Trinh, H. N., Nguyen, H. A., … Nguyen, M. H. (2015). Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ Open Gastroenterology, 2(1).
Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis. Yee, B. E., Nguyen, N. H., Zhang, B., Lin, D., Vutien, P., Wong, C. R., … Nguyen, M. H. (2015). Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis. BMJ Open Gastroenterology, 2(1).
Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis Zhang, B., Nguyen, N. H., Yee, B. E., Yip, B., Ayoub, W. S., Lutchman, G. A., & Nguyen, M. H. (2015). Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. INTERVIROLOGY, 58(4), 242–49.
Current Treatment Options in Patients with Hepatitis C Virus Genotype 6 Nguyen, N. H., & Nguyen, M. H. (2015). Current Treatment Options in Patients with Hepatitis C Virus Genotype 6. Gastroenterol Clin N Am, 44.
Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation. Uribe, L. A., Nguyen, N., Kim, L., Trinh, H. N., Wong, C., Wong, C., … Nguyen, M. H. (2016). Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation. Digestive Diseases and Sciences, 61(2), 618–625.
Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy. Chaung, K. T., O'Brien, C., Ha, N. B., Nguyen, N. H., Trinh, H. N., & Nguyen, M. H. (2016). Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy. Journal of Clinical Gastroenterology, 50(4), 338–344.
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. Feld, J. J., Jacobson, I. M., Hézode, C., Asselah, T., Ruane, P. J., Gruener, N., … Zeuzem, S. (2015). Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. The New England Journal of Medicine, 373(27), 2599–607.
HCV Prevalence in Asian Americans in California. Lin, O. N., Chang, C., Lee, J., Do, A., Martin, M., Martin, A., & Nguyen, M. H. (2016). HCV Prevalence in Asian Americans in California. Journal of Immigrant and Minority Health, -?
Current Treatment Options in Patients with Hepatitis C Virus Genotype 6. Nguyen, N. H., & Nguyen, M. H. (2015). Current Treatment Options in Patients with Hepatitis C Virus Genotype 6. Gastroenterology Clinics of North America, 44(4), 871–881.
Management of Chronic hepatitis C among Asian Americans. Yip, B., Nguyen, L. H., & Nguyen, M. H. (2014). Management of Chronic hepatitis C among Asian Americans. . North Am J Med Sci. , 7.
Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma Chen, V. L., Le, A. K., Kim, N. G., Kim, L. H., Nguyen, N. H., Nguyen, P. P., … Nguyen, M. H. (2016). Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 14(6), 887-?
Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study Ahn, J., Lee, H. M., Lim, J. K., Pan, C. Q., Nguyen, M. H., Kim, W. R., … Lok, A. S. (2016). Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 43(1), 134–144.
Analysis of HCV-6 isolates among Asian-born immigrants in North America reveals their high genetic diversity and a new subtype Lu, L., Wu, T., Xiong, L., Li, C., Nguyen, M. H., & Murphy, D. G. (2016). Analysis of HCV-6 isolates among Asian-born immigrants in North America reveals their high genetic diversity and a new subtype. VIROLOGY, 492, 25–31.
Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited. Leong, J., Lin, D., & Nguyen, M. H. (2016). Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited. World Journal of Clinical Cases, 4(3), 71–5.
Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis. Nguyen, N. H., Yee, B. E., Chang, C., Jin, M., Lutchman, G., Lim, J. K., & Nguyen, M. H. (2016). Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis. BMJ Open Gastroenterology, 3(1).
Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials. Yee, B. E., Nguyen, N. H., Jin, M., Lutchman, G., Lim, J. K., & Nguyen, M. H. (2016). Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials. BMJ Open Gastroenterology, 3(1).
Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice Ha, N. B., Trinh, H. N., Rosenblatt, L., Nghiem, D., & Nguyen, M. H. (2016). Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice. JOURNAL OF CLINICAL GASTROENTEROLOGY, 50(2), 169–174.
Hepatocellular Carcinoma Screening and Surveillance Practice Guidelines and Real-Life Practice Zhao, C., & Nguyen, M. H. (2016). Hepatocellular Carcinoma Screening and Surveillance Practice Guidelines and Real-Life Practice. JOURNAL OF CLINICAL GASTROENTEROLOGY, 50(2), 120–133.
Racial Disparities in Treatment Rates for Chronic Hepatitis C Analysis of a Population-Based Cohort of 73,665 Patients in the United States Vutien, P., Hoang, J., Brooks, L., Nguyen, N. H., & Nguyen, M. H. (2016). Racial Disparities in Treatment Rates for Chronic Hepatitis C Analysis of a Population-Based Cohort of 73,665 Patients in the United States. MEDICINE, 95(22).
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. Ahn, J., Lim, J. K., Lee, H. M., Lok, A. S., Nguyen, M., Pan, C. Q., … Kim, W. R. (2016). Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. American Journal of Gastroenterology, 111(9), 1297–1304.
Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B. Chang, C. Y., Aziz, N., Poongkunran, M., Javaid, A., Trinh, H. N., Lau, D., & Nguyen, M. H. (2016). Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B. American Journal of Gastroenterology, 111(10), 1410–1415.
Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection Nguyen, L. H., Hoang, J., Nguyen, N. H., Vu, V. D., Wang, C., Trinh, H. N., … Nguyen, M. H. (2016). Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 44(4), 390–399.
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-label, Phase 2 Trial. Gane, E., Kowdley, K. V., Pound, D., Stedman, C. A. M., Davis, M., Etzkorn, K., … Nguyen, M. H. (2016). Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-label, Phase 2 Trial. Gastroenterology.
Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study. Ladenheim, M. R., Kim, N. G., Nguyen, P., Le, A., Stefanick, M. L., Garcia, G., & Nguyen, M. H. (2016). Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study. BMJ Open Gastroenterology, 3(1).
Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. Hoang, J. K., Yang, H.-I., Le, A., Nguyen, N. H., Lin, D., Vu, V. D., … Nguyen, M. H. (2016). Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. Medicine, 95(31).
Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1. Lutchman, G., Nguyen, N. H., Chang, C. Y., Ahmed, A., Daugherty, T., Garcia, G., … Nguyen, M. H. (2016). Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1. Alimentary Pharmacology & Therapeutics, 44(7), 738–746.
Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients. LIN, D., Yang, H., Nguyen, N., Hoang, J., Kim, Y., Vu, V., … Nguyen, M. H. (2016). Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients. Alimentary Pharmacology & Therapeutics, 44(8), 846–55.
Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States. Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States. (2016). Cancer.
Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Wang, C., Chen, V., Vu, V., Le, A., Nguyen, L., Zhao, C., … Nguyen, M. H. (2016). Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Medicine, 95(35).
Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma. Kutsenko, A., Ladenheim, M. R., Kim, N., Nguyen, P., Chen, V., Jayasekera, C., … Nguyen, M. H. (2017). Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma. Journal of Clinical Gastroenterology, 51(4), 384–390.
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease Wong, C. R., Nguyen, M. H., & Lim, J. K. (2016). Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. WORLD JOURNAL OF GASTROENTEROLOGY, 22(37), 8294–8303.
Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. Oh, H., Jun, D. W., Saeed, W. K., & Nguyen, M. H. (2016). Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. Clinical and Molecular Hepatology, 22(3), 327–335.
Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients. Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Levitt, B. S., Nguyen, K., … Nguyen, M. H. (2014). Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients. Clinical Gastroenterology and Hepatology , 12(8), 1363–1370.
Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply. Lin, D., Yang, H.-I. I., Hoang, J., & Nguyen, M. H. (2017). Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply. Alimentary Pharmacology & Therapeutics, 45(1), 186–187.
Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply. Lin, D., Yang, H.-I. I., Hoang, J., & Nguyen, M. H. (2017). Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply. Alimentary Pharmacology & Therapeutics, 45(1), 182–183.
Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia. Kim, Y. A., Estevez, J., Le, A., Israelski, D., Baatarkhuu, O., Sarantuya, T., … Nguyen, M. H. (2016). Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia. BMJ Open Gastroenterology, 3(1), e000119.
Antibody-dependent and -independent uptake of HBsAg across human leukocyte subsets is similar between individuals with chronic hepatitis B Virus infection and healthy donors. Tharinger, H., Rebbapragada, I., Samuel, D., Novikov, N., Nguyen, M., Jordan, R., … Pflanz, S. (2016). Antibody-dependent and -independent uptake of HBsAg across human leukocyte subsets is similar between individuals with chronic hepatitis B Virus infection and healthy donors. Journal of Viral Hepatitis.
The Cascade of Care in Chronic Hepatitis B Liou, I. W., & Nguyen, M. H. (2016). The Cascade of Care in Chronic Hepatitis B. Current Hepatitis Reports, 15.
Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease. Chang, C. Y., Nguyen, P., Le, A., Zhao, C., Ahmed, A., Daugherty, T., … Nguyen, M. H. (2017). Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease. Medicine, 96(6).
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV cirrhosis with Normal Alanine Transaminase. Yang, J. D., Dai, J., Singal, A. G., Gopal, P., Addissie, B., Nguyen, M. H., … Roberts, L. R. (2017). Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV cirrhosis with Normal Alanine Transaminase. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
Ledipasvir and sofosbuvir combination for hepatitis C virus infection in three patients aged 85 years and older. Ji, F., Tian, C., Li, Z., Deng, H., & Nguyen, M. H. (2017). Ledipasvir and sofosbuvir combination for hepatitis C virus infection in three patients aged 85 years and older. European Journal of Gastroenterology & Hepatology.
Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B. Chang, C. Y., Aziz, N., Poongkunran, M., Javaid, A., Trinh, H. N., Lau, D. T., & Nguyen, M. H. (2017). Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B. Journal of Clinical Gastroenterology.
Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States Le, M. H., Devaki, P., Ha, N. B., Jun, D. W., Te, H. S., Cheung, R. C., & Nguyen, M. H. (2017). Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLOS ONE, 12(3).
HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis. Lee, M.-H., Hsiao, T. I., Subramaniam, S. R., Le, A. K., Vu, V. D., Trinh, H. N., … Nguyen, M. H. (2017). HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis. American Journal of Gastroenterology.
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients from the US Multicenter HCC Transplant Consortium. Agopian, V. G., Harlander-Locke, M. P., Ruiz, R. M., Klintmalm, G. B., Senguttuvan, S., Florman, S. S., … Busuttil, R. W. (2017). Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients from the US Multicenter HCC Transplant Consortium. Annals of Surgery.
Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis. Okada, M., Enomoto, M., Kawada, N., & Nguyen, M. H. (2017). Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis. Expert Review of Gastroenterology & Hepatology.
Epidemiology of hepatitis B and the role of vaccination. Chang, M. S., & Nguyen, M. H. (2017). Epidemiology of hepatitis B and the role of vaccination. Best Practice & Research. Clinical Gastroenterology, 31(3), 239–47.
Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar. Kim, Y. A., Trinh, S., Thura, S., Kyi, K. P., Lee, T., Sze, S., … Nguyen, M. H. (2017). Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar. PloS One, 12(8), e0181603.
Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response. Le, A. K., Zhao, C., Hoang, J. K., Tran, S. A., Chang, C. Y., Jin, M., … Nguyen, M. H. (2017). Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response. Alimentary Pharmacology & Therapeutics.
Management of Chronic Hepatitis B in Pregnancy. Li, J., Chang, M. S., Tran, T. T., & Nguyen, M. H. (2017). Management of Chronic Hepatitis B in Pregnancy. Journal of Clinical Gastroenterology.
Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue. Zhao, C., Jin, M., Le, R. H., Le, M. H., Chen, V. L., Jin, M., … Nguyen, M. H. (2017). Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue. Liver International : Official Journal of the International Association for the Study of the Liver.
Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis. Vutien, P., Jin, M., Le, M. H., Nguyen, P., Trinh, S., Huang, J.-F. F., … Nguyen, M. H. (2017). Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis. PloS One, 12(9), e0183851.
Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers. Chen, V. L., Le, A. K., Podlaha, O., Estevez, J., Li, B., Vutien, P., … Nguyen, M. H. (2017). Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers. Scientific Reports, 7(1), 11169.
Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma. Estevez, J., Chen, V. L., Podlaha, O., Li, B., Le, A., Vutien, P., … Nguyen, M. H. (2017). Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma. Scientific Reports, 7(1), 11867.
Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease. Wong, C. R., Njei, B., Nguyen, M. H., Nguyen, A., & Lim, J. K. (2017). Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics.
Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics. Hsu, Y.-C. C., Wei, M. T., & Nguyen, M. H. (2017). Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics. Expert Review of Gastroenterology & Hepatology.
Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis. Goel, A., Rahim, U., Nguyen, L. H., Stave, C., & Nguyen, M. H. (2017). Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis. Alimentary Pharmacology & Therapeutics.

View All 167 Publications

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Clinical Trials View All »

The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

4.8

Friendliness

4.8

Friendliness

4.7

Explanations

4.7

Explanations

4.7

Listens

4.7

Listens

4.7

Includes you in decisions

4.7

Includes you in decisions

4.7

Clear Communication

4.7

Clear Communication

4.7

Confidence in your doctor

4.7

Confidence in your doctor

4.7

Recommended to others

4.7

Recommended to others

4.3

Wait times

4.3

Wait times

SHC Patient, Aug 2017

Good.

SHC Patient, Jul 2017

Good.

SHC Patient, Apr 2017

Provider knowledgeable; very thorough; asked many questions.

SHC Patient, Mar 2017

Good.

SHC Patient, Mar 2017

Great service.

SHC Patient, Mar 2017

It would be nice if care provider took a little time to explain in detail my test results. "Everything is fine & the same as last test results" somehow doesn't make me feel reassured.

SHC Patient, Feb 2017

Stanford is awesome. Dr. Mindie Nguyen is an angel in disguise!

SHC Patient, Feb 2017

Dr.Mindie Nguyen is the best doctor

SHC Patient, Feb 2017

I am honored by having this extraordinary doctor Nguyn care for my health through treatment and recovery. Stanford is fortunate to have such a wonderful asset.

SHC Patient, Jan 2017

Good service.

SHC Patient, Jan 2017

Dr. Mindie is my hero -

SHC Patient, Dec 2016

Very good.

Patient Comments

Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

SHC Patient, Aug 2017

Good.

SHC Patient, Jul 2017

Good.

SHC Patient, Apr 2017

Provider knowledgeable; very thorough; asked many questions.

SHC Patient, Mar 2017

Good.

SHC Patient, Mar 2017

Great service.

SHC Patient, Mar 2017

It would be nice if care provider took a little time to explain in detail my test results. "Everything is fine & the same as last test results" somehow doesn't make me feel reassured.

SHC Patient, Feb 2017

Stanford is awesome. Dr. Mindie Nguyen is an angel in disguise!

SHC Patient, Feb 2017

Dr.Mindie Nguyen is the best doctor

SHC Patient, Feb 2017

I am honored by having this extraordinary doctor Nguyn care for my health through treatment and recovery. Stanford is fortunate to have such a wonderful asset.

SHC Patient, Jan 2017

Good service.

SHC Patient, Jan 2017

Dr. Mindie is my hero -

SHC Patient, Dec 2016

Very good.

SHC Patient, Dec 2016

good

SHC Patient, Nov 2016

Friendliness. Very kind. Recommended to other.

SHC Patient, Oct 2016

Good.

SHC Patient, Oct 2016

Good.

SHC Patient, Oct 2016

The doctor is excellent. the blood lab is understaffed.

SHC Patient, Oct 2016

Good.

SHC Patient, Sep 2016

very knowledgeable doctor. hope participate on future research work with her

SHC Patient, Sep 2016

Good.

SHC Patient, Sep 2016

Dr. Nyguen is awesome. As are her clinical coordinators.

SHC Patient, Sep 2016

Good.

SHC Patient, Apr 2016

She is a good listener, also she explain clearly the plan she will do with me.

SHC Patient, Mar 2016

Dr. Nguyen was great!! Same caliber as Dr. Ayoub who is no longer with you.

SHC Patient, Mar 2016

I fill very comfortable and confident

SHC Patient, Nov 2015

Best experience.

SHC Patient, Nov 2015

Dr. Mindie Nguyen is a SAINT!!

SHC Patient, Oct 2015

Perhaps it is that my health condition is in excellent shape. Hence, my doctor does not really show much of concern on my Hep-B test results.

SHC Patient, Aug 2015

Very Good

SHC Patient, Jul 2015

Excellent

SHC Patient, Jun 2015

Great, knowledgeable, compassionate doctor!

SHC Patient, Jun 2015

our care provider that day is the absolute BEST!!! We have complete confidence in her.

SHC Patient, May 2015

Excellent

SHC Patient, May 2015

Dr. Nyugen is extremely knowledgeable and easy to converse with

SHC Patient, Feb 2015

Very good!

SHC Patient, Sep 2014

I have been a patient with Dr. Nguyen for a very long time. She has always made me feel that I was being cared for with the utmost ability. I would recommend her to anybody -

SHC Patient, Jul 2014

Good.

SHC Patient, Jun 2014

Mindy has been my doctor for a long time. She has been concerned in the best way possible about me in categories of my health.

SHC Patient, May 2014

Dr. Nguyen is superb! Very social - Enjoy talking with her during visits.

SHC Patient, Mar 2014

Good - doctor to have, to keep.

SHC Patient, Feb 2014

I liked the fact that she printed out all the instructions.

SHC Patient, Feb 2014

Good.

Alcohol Hepatitis

Alcohol-Induced Liver Disease

Autoimmune Hepatitis

Chronic Liver Disease

Cirrhosis

Drug Induced Hepatitis

Fatty Liver Disease

Gallstones

Hemochromatosis

Hepatitis

Hepatitis A

Hepatitis B

Hepatitis C

Hepatitis D

Hepatology (Liver Conditions)

Liver Cancer

Liver Transplant

Polycystic Liver Disease

New to MyHealth?

MyHealth for Mobile

WELCOME BACK

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD